Altered bone metabolism in inflammatory bowel disease: There is a difference between Crohn's disease and ulcerative colitis

Journal of Internal Medicine

Volumn 247, Issue 1, 2000, Pages 63-70

  Ardizzone, S ^a   Bollani, S ^a   Bettica, P ^a   Bevilacqua, M ^a   Molteni, P ^a   Porro, G Bianchi ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone metabolism; Crohn's disease; Osteoporosis; Ulcerative colitis

Indexed keywords

ALKALINE PHOSPHATASE; CALCIFEDIOL; COLLAGEN TYPE 1; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISOLONE;

ADULT; AGE; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; SEX DIFFERENCE; STEROID THERAPY; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CALCIFEDIOL; CALCITRIOL; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PREDNISOLONE; REGRESSION ANALYSIS; SEX FACTORS;

EID: 0033979309     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00582.x     Document Type: Article

References (28)

1. 1 Compston JE, Judd D, Crawely EO et al. Osteoporosis in patients with inflammatory disease. Gut 1987; 28: 410-15.
2. 2 Pigot F, Roux C, Chaussade S et al. Low bone mineral density in patients with inflammatory bowel diseuse. Dig Dis Sci 1992; 37: 1396-403.
3. 3 Ljunghall S., Ljunggren ?. Inflammatory bowel disease and osteoporosiS. Ital J Gastroenterol Hepatol 1999; 31: 103-109.
4. 4 Silvennoinen JA, Karttunen TJ, Niemelä SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995; 37: 71-76.
5. 5 Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107: 1031-39.
6. 6 Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40: 228-33.
7. 7 Hylander E, Ladefoged K, Madsen S. Calcium balance and bone mineral content following small intestinal resection. Scand J Gastroenterol 1981; 16: 167-76.
8. 8 Tromm A, Rickels K, Huppe D, Wiebe V, May B. Risk factors for osteoporosis (OP) in inflammatory bowel disease (IBD) (abstract). Gastroenterology 1993; 105: A542.
9. 9 Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988; 29: 1332-36.
10. 10 Issenman RM, Atkinson SA, Fraser D, Greenway S, Ferraton F. Prednisolone and bone mineral mass in adolescent Crohn's disease (CD). Gastroenterology 1988; 94: A201.
11. 11 Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is redueed in patients with Crohn's disease but not in patients with ulcerative colitis. Gut 1997; 40: 313-19.
12. 12 Mazlam MZ, Hodgson HJF. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992; 33: 773-78.
13. 13 Raisz LG. Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 1998; 318: 818-28.
14. 14 Macdonald BR, Gowen M. Cytokines and bone. Br J Rheumatol 1992; 31: 149-55.
15. 15 Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P. Interleukin-1 stimulates bone resorption and inhibits formation in vivo. Lymphokine Cytokine Res 1991; 10: 15-21.
16. 16 Best WR, Becktel JM, Singleton JW, Kern R. Development of a Crohn's disease activity index. Gustroenterology 1976; 70: 439-44.
17. 17 Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955; 2: 1041-44.
18. 18 World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series 843. Geneva: WHO, 1994.
19. 19 Hyams JS, Wyzga N, Kreutzer DL. Justinich CJ, Gronowicz GA. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr 1997; 24: 289-95.
20. 20 Shanahan F. Pathogenesis of ulcerative colitis. Lancet 1993; 342: 407-11.
21. 21 Eastell R, Reid DM, Compston J et al. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998; 244: 271-92.
22. 22 Francis RM, Peacock M, Aaron JF. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-hydroxy-vitamin D, calcium metabolism and low bone formation. Bone 1986; 7: 261-68.
23. 23 Robinson RJ, Iqbal SJ, Al-Azzawi F, Abrams K, Mayberry JF. Sex hormone status and bone metabolism in men with Crohn's disease. Aliment Pharmacol Ther 1998; 12: 21-25.
24. 24 Bischoff SC, Herrmann A, Göke M, Manns MP, von zur Mühlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997; 92: 1157-63.
25. 25 Robinson RJ, Iqbal SJ, Abrams K, Al-azzawis F, Mayberry JF. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998; 12: 699-705.
26. 26 Abitbol V, Roux C, Chaussade S et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417-22.
27. 27 Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis Int 1993: 3: 236-41.
28. 28 Peck W, Gennari C, Raisz L et al. Corticosteroids and bone. Calcif Tissue Int 1984; 36: 4-7.